CIRIN has been very aggressively pursuing its objective to widen and diversify its product base. In the last one year, the company has launched five new products, including a vaccine (Abhayrab®). Cataplas (Capsules and Liquid Injections) and Fermax (Liquid Injections) are the latest products being handed over to CIRIN's marketing team.
Both Cataplas® and Fermax® are result of thorough market research and years of efficacy & stability studies conducted at CIRIN. These products add to an already impressive basket of the company as well as meant to address healthcare needs of a large portion of country’s population.




Informal Cake-Cutting Ceremony:


